RECRUITING

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The field of transcatheter tricuspid valve replacement (TTVR) is rapidly emerging and data on this topic are scarce. Particularly, little is known about which patients are at greatest risk of procedural complications, such as the timing and onset of conduction disturbances necessitating permanent pacemaker implantation, and how such patients are managed. On this background, the TRIPLACE Registry - an investigator-initiated global multicenter registry - is aimed at better understanding the safety and efficacy of orthotopic TTVR.

Official Title

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment: the TRIPLACE Registry

Quick Facts

Study Start:2023-10-05
Study Completion:2026-08
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06033274

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Patients undergoing Transcatheter Tricuspid Valve Replacement
  2. * Native Tricuspid Valve disease
  3. * Orthotopic Tricuspid Valve Implantation
  1. * Age under 18 years

Contacts and Locations

Study Contact

Andrea Scotti, MD
CONTACT
7189043388
ascotti@montefiore.org
Rishi Puri, MD
CONTACT
(216) 444-2273
purir@ccf.org

Principal Investigator

Andrea Scotti, MD
PRINCIPAL_INVESTIGATOR
Montefiore Medical Center
Azeem Latib, MD
PRINCIPAL_INVESTIGATOR
Montefiore Medical Center
Rishi Puri, MD
PRINCIPAL_INVESTIGATOR
The Cleveland Clinic
Neil Fam, MD
PRINCIPAL_INVESTIGATOR
St. Michaels Hospital
Thomas Modine, MD
PRINCIPAL_INVESTIGATOR
University Hospital, Bordeaux

Study Locations (Sites)

Arizona Heart Hospital (Biltmore Cardiology)
Phoenix, Arizona, 85016
United States
Columbia University Irving Medical Center
New York, New York, 10032
United States
Montefiore Medical Center
The Bronx, New York, 10461
United States
Cleveland Clinic
Cleveland, Ohio, 44195
United States
Oregon Health & Science University
Portland, Oregon, 97239
United States

Collaborators and Investigators

Sponsor: Montefiore Medical Center

  • Andrea Scotti, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center
  • Azeem Latib, MD, PRINCIPAL_INVESTIGATOR, Montefiore Medical Center
  • Rishi Puri, MD, PRINCIPAL_INVESTIGATOR, The Cleveland Clinic
  • Neil Fam, MD, PRINCIPAL_INVESTIGATOR, St. Michaels Hospital
  • Thomas Modine, MD, PRINCIPAL_INVESTIGATOR, University Hospital, Bordeaux

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-10-05
Study Completion Date2026-08

Study Record Updates

Study Start Date2023-10-05
Study Completion Date2026-08

Terms related to this study

Keywords Provided by Researchers

  • valvular heart disease
  • tricuspid regurgitation
  • transcatheter tricuspid valve replacement

Additional Relevant MeSH Terms

  • Tricuspid Regurgitation